The US FDA has granted Fast Track Designation to SOTIO [...]

Skyhawk Therapeutics has expanded its global pivotal Phase 2/3 clinical [...]

Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]

Novogene Europe has expanded its Cambridge Omics Centre with the [...]

ProMIS Neurosciences has reported the first human evidence that its [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

Q32 Bio has reported positive 36-week Phase 2 data showing [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

Messenger RNA (mRNA) technology could offer a new approach to [...]